News | March 26, 2012

Femasys Partners With Bayer to Distribute FemVue in Japan

March 22, 2012 -- Femasys Inc., a medical device developer of women's healthcare solutions, announced an agreement with Bayer Yakuhin Ltd., Osaka, Japan, for exclusive distribution rights in Japan for Femasys' FemVue Saline-Air Device.  This is the first device that allows physicians to quickly and effectively evaluate with ultrasound a woman's fallopian tubes, a critical component of her fertility assessment. The FemVue evaluation procedure can be performed reliably and safely (no radiation), in the physician's office or any facility with ultrasound, in a cost-effective and convenient procedure. Whether performing FemVue as part of an initial fertility work-up or to reconfirm fallopian tube status prior to other procedures, its innovative design allows for easy adoption into any practice.

"Our partnership with Bayer now provides physicians in Japan access to our FemVue Saline-Air Device for fallopian tube assessment as a first step in infertility diagnosis or as a part of fertility confirmation," stated Kathy Lee-Sepsick, president & CEO of Femasys Inc. "There is no better partner to introduce FemVue to the Japanese market than Bayer and we have ramped production accordingly to support the commercialization efforts underway."

Bayer Yakuhin Ltd., a wholly-owned subsidiary of the Bayer HealthCare Corporation, has marketing authorization from the Ministry of Health, Labor and Welfare (MHLW) to promote FemVue through their world-class sales channel. The FemVue Saline-Air Device has marketing clearance in the United States, Europe, Canada and Japan.  FemVue is currently distributed in the United States by Norgenix, LLC.

For more information: www.femasys.com

Related Content

ABUS: An Important Companion to Traditional Mammography

The multi-use ultrasound breast system Acuson S2000 Automated Breast Volume Scanner (ABVS) from Siemens Healthineers automatically acquires volume images of the breast. Photo courtesy of Siemens.

Feature | Ultrasound Women's Health | April 18, 2018 | Emily Clemons
Research shows that automated br...
2018 Set to be Strong for the Global Ultrasound Market
Feature | Ultrasound Imaging | April 18, 2018 | Simon Harris
After a year of mixed fortunes, the global ultrasound market is set for a strong year in 2018.
DenseBreast-info.org Celebrates Third Anniversary
News | Breast Density | April 17, 2018
April 2018 marks the third anniversary of the launch of DenseBreast-info.org, the educational resource for medically...
Technology | Breast Density | April 13, 2018
Densitas Inc. has received U.S. Food and Drug Administration (FDA) clearance for its DENSITAS|density automated breast...
Volpara Solutions and Mammography Educators Launch Mammography Positioning Training Videos
News | Mammography | April 12, 2018
Volpara Solutions Inc. and mammography education provider Mammography Educators LLC announced the launch of training...
Ikonopedia Introduces Enhanced Breast Ultrasound Reporting Module at SBI
News | Ultrasound Women's Health | April 11, 2018
Ikonopedia will introduce its next-generation breast ultrasound reporting module at the 2018 Society for Breast Imaging...
ACR/SBI Breast Cancer Screening Guidelines Reclassify African-American Women as High-Risk
News | Breast Imaging | April 06, 2018
New American College of Radiology (ACR) and Society of Breast Imaging (SBI) breast cancer screening guidelines are the...
News | Oncology Diagnostics | April 05, 2018
April 5, 2018 — Myriad Genetic Laboratories Inc.
Wisconsin Gov. Walker Signs Breast Density Reporting Bill
News | Breast Density | April 05, 2018 | Jeff Zagoudis, Associate Editor
Wisconsin Gov. Scott Walker made the Badger State the 35th state to report dense breast tissue to patients as part of...
Diagnosing Breast Cancer Using Red Light

Schematic diagram for OM instrument: Seven pulsed lasers sequentially illuminate the compressed breast; transmitted light is detected by the 8-channel SiPM probe and the TDC acquires the signal. Credit: Edoardo Ferocino

News | Breast Imaging | April 02, 2018
Optical mammography (OM), which uses harmless red or infrared light, has been developed for use in conjunction with X-...
Overlay Init